India's Pharmaceutical Exports

Country Profile

New Zealand

New Zealand is a growing market for Indian pharmaceuticals — $63.4M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $192K. The compound annual growth rate since FY2015 stands at 5.0%.

🇳🇿 $63.4M · 1.7× growth since FY2015 · 5.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$63.4M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
5.0%
CAGR FY2015→2026
91%
Medicines Share
5
Product Categories Supplied
New Zealand is a growing market for Indian pharmaceuticals — $63.4M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 91% of shipments, with vaccines contributing $192K. The compound annual growth rate since FY2015 stands at 5.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $57.6M (90.9%) Surgical & Hospital Supplies $2.22M (3.5%) Medicine Ingredients $2.04M (3.2%) Traditional & Herbal $1.29M (2.0%) Vaccines $192K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to New Zealand in the RBI overseas direct investment dataset (2011–2026).